Charting the Course of Post-Acute and Long-Term Care Medicine Presentation: Navigating the Choppy Waters of Medical Cannabis.

Slides:



Advertisements
Similar presentations
Aug 7 09 Co-Occurring Service Array Psychiatric Evaluation Comprehensive Evaluation Medication Monitoring Medications Clinical Consultation Family Therapy.
Advertisements

Constitutional Amendment on Medical Marijuana Open Discussion Item Board of County Commissioners June 3, 2014.
HB 1 Presentation Judiciary Non-Civil House Committee.
1 Medical Marijuana: Around the Country Presented by: Anna Rau of MontanaPBS September 20, 2011.
Compassionate Care NY Vince Marrone. Compassionate Care Act Purpose is to allow New Yorkers with serious medical conditions access to medical marijuana.
Achieving Better Care by Monitoring All Prescriptions (ABC-MAP) Act 191 of 2014 Board Meeting April 8, 2015.
Medical Marijuana Registry Ron Hyman State Registrar Ann Hause Director, Office of Legal and Regulatory Affairs.
Medical Marijuana State Implementation Ryan Padgett Assistant General Counsel Florida League of Cities Template courtesy of Susan Trevarthan - Weiss Serota.
Straight Talk On Medical Marijuana Laws. Controlled Substance Laws State Prohibition 99% of marijuana arrests are under state laws Federal Prohibition.
Pain Management: a Regulatory Perspective William J. Schmidt, J.D. Senior Counsel, Investigations, Compliance & Enforcement Randy Beck Investigative Supervisor.
Health and Wellness for all Arizonans azdhs.gov Arizona Association for Home Care Presentation Arizona Department of Health Services July 25, 2015.
Michigan Medical Marihuana Program Michigan Department of Community Health Bureau of Health Professions April 14, 2009.
The Medical Marihuana Act: An Overview Melanie B. Brim Director Bureau of Health Professions Michigan Department of Community Health.
ARIZONA’S MEDICAL MARIJUANA INITIATIVE DOUGLAS W. HEBERT F]
2013 Michigan Medical Marijuana Law Update Matthew R. Abel Attorney at Law Cannabis Counsel, PLC 2930 E Jefferson Ave, Detroit, MI
Medical Marijuana and The Workplace. Presented by: Brenda JM Sabin, CBP Dir of HR Compliance & Payroll Solutions.
Medicaid Hospital Utilization Review and DRG Audits: Frequently Asked Questions The Department of Medical Assistance Services Division of Program Integrity.
Medical Marijuana in the United States A Brief History SW IALEP Chapter Glendale, Arizona February 8, 2011.
MEDICINAL MARIJUANA By Chris Ciely. In 2010 the Congressional Research Service stated: “Two bills that have been introduced in recent Congresses are.
1 Maine’s New Medicinal Marijuana Law Maine Association of Psychiatric Physicians April 30, 2010 Gordon H. Smith, Esq. Executive Vice President Maine Medical.
Managing Pre-Hospital Exposures PRODUCED BY RI Department of Health, Division of EMS & Hospital Association of Rhode Island.
Trends in State Medical Marijuana Policies Karen O’Keefe, Esq. Director of State Policies Marijuana Policy Project.
Department of Health Professions Workgroup on SB1167 Overview of Drug Control Act and Good Samaritan Provisions May 27, 2015 Caroline D. Juran, Executive.
Prescription Drug Monitoring Programs: Analysis of State Level Usage Requirements Matthew Penn, JD, Carla Chen, JD Director, Public Health Law Program.
ARIZONA’S MEDICAL MARIJUANA INITIATIVE DOUGLAS W. HEBERT F]
Smoking in the Rockies Colorado’s Medical Marijuana Registry Ron Hyman, State Registrar.
Department of Health and Vanderbilt University Chronic Pain Guidelines Symposium Elizabeth Lund, Executive Director, Board of Nursing Linda Johnson, APN.
ACCESS TO MEDICINES - POLICY AND ISSUES
© 2013 The McGraw-Hill Companies, Inc. All rights reserved. Ch 8 Privacy Law and HIPAA.
Texas State Board of Medical Examiners Bruce A. Levy, M.D., J.D.
©2013 MFMER | 1 Kris Negley, APRN, CNS Jeanne Voll, APRN, CNS Clinical Nurse Specialists CNS Role in Creating Processes for Patient Use of Medical Cannabis.
WISHA, 7/23/04 Employee Medical and Exposure Records Chapter WAC Employer Responsibilities.
“House votes to legalize medical marijuana in Pennsylvania” i.
Georgia’s New and Improved PDMP. Greg Reybold, J.D. VP Public Policy & Association Counsel Georgia Pharmacy Association.
Denis G. Patterson, DO ECHO Project April 20, 2016 CDC Guidelines for Prescribing Opioids for Chronic Pain.
Doctor – Patient Contract Dr Hidayathulla Shaikh, Lecturer, College of Dentistry, Majmaah University.
Juvenile Legislative Update 2013 Confidentiality of Records and Interagency Sharing of Educational Records.
Sue Sisley, MD June 24, 2016 Virgin Islands Committee on Health Testimony.
Achieving Better Care by Monitoring All Prescriptions (ABC-MAP) Act 191 of 2014 Pennsylvania's Prescription Drug Monitoring Program (PDMP) May 17, 2016.
HIPAA Training Workshop #3 Individual Rights Kaye L. Rankin Rankin Healthcare Consultants, Inc.
Medication Assisted Treatment
Objectives Upon completion of this training, agencies will be able to:
Substance Addiction(Compulsory Assessment and Treatment) Act 2017 Processes
Maryland Prescription Drug Monitoring Program (PDMP)
Lawyer Paralegals and related occupations perform research and document preparation duties in law firms, legal departments in the private and public.
Access to Employee Exposure and Medical Records
Section 504 of the Rehabilitation Act
Weed Use and Its Various Health Benefits. Medical Cannabis Directory Cannabis or medical marijuana has long been known to alleviate chronic pain symptoms.
Susan y swart Ed.D, rn, cae Executive director Ana-Illinois
PRESENTATION ON CODING COMPLIANCE ISSUES
From Exam Room to Courtroom
Telepractice Delivery of Services in OASAS Programs.
North Dakota Department of Health Division of Medical Marijuana
NPDB National Practitioner Data Bank - CQ
April 12, 2017 Guy Reese, Program Integrity Manager
What is the Family and Medical Leave Act?
Access to Employee Exposure and Medical Records
Medical Cannabis in Maryland: Legal Issues and Implications
DATE : 19 June 2018 BY : Palesa Santho
Flash Talk Can Medical Marijuana Be a Solution to the Opioid Crisis?
Clinical Cannabis Interprofessional Education: Program Development and Provider Knowledge Cameron, M.H. 1,2 & Jones, K.D.3,4 1. VA Portland Health Care.
Medical Marijuana: Next steps for Oklahoma employers
National Credentialing Forum 2019 San Diego, CA February
Illinois Prescription Monitoring Program
Weeding through the Pennsylvania Medical Marijuana Act
PMP Advisory Committee
Medical Cannabis Program at Bellbrook Family Practice
Using the NBCP for Ohio’s Medical Marijuana Program
Presentation transcript:

Charting the Course of Post-Acute and Long-Term Care Medicine Presentation: Navigating the Choppy Waters of Medical Cannabis Presenter: William D. Shaughnessy, Jr., Esq. wshaughnessy@gfrlaw.com

Disclosure of Interest Mr. Shaughnessy provides legal services to medical cannabis growers in Maryland – SunMed Growers, LLC – and to the trade association of Maryland medical cannabis growers - CANMD

Navigating the Choppy Waters of Medical Cannabis Objective: Gain an understanding of the laws regarding medical cannabis

Legal Background Medical Cannabis is Federally illegal Schedule 1 drug under Controlled Substances Act – no prescription Consequences: possible arrest, forfeiture, etc. Few studies on medical efficacy of cannabis Medical Cannabis is legal under laws of some States As of 2018, 31 states plus DC and Puerto Rico have legalized the use of medical cannabis for certain conditions

Legal Background, cont’d Conflict between Federal and State law Risks of federal prosecution of activity that is legal under state law. “Rohrbacher amendment” – no DOJ funding for federal interference of state legal cannabis. January 2018 - Sessions withdrew Obama era guidance known as Cole Memorandum U.S. attorney discretion

General Framework of State Laws State legislation and regulations passed Medical certification/recommendation Registration of qualifying patient Medical cannabis card issued Medical cannabis obtained by registered qualified patient at regulated outlets THUS, AUTHORIZATION IS BY STATE, NOT MEDICAL PROVIDER

State legalization- Maryland – law effective 10/1/2013; regs effective 9/14/ 2015 Md. Code, Health-Gen. § 13-3301 COMAR 10.62.01.01 et seq. Regulatory authority: Maryland Medical Cannabis Commission https://mmcc.maryland.gov/Pages/home.aspx

State legalization- Delaware – law effective 7/1/2011; regs effective 6/11/ 2012 Del. Code Title 16, Chapter 49A 16 Del. Admin. Code Chapter 4470 Regulatory authority Office of Medical Marijuana, Division of Public Health https://dhss.delaware.gov/dph/hsp/medmarhome.html

State legalization- D.C. District of Columbia law effective 7/27/2010; regs effective 12/2/2011 D.C. Code § 7-1671.01 et seq. 22-C DCMR § 100 et seq. Regulatory authority: Division of Medical Marijuana and Integrative Therapy, Department of Health https://dchealth.dc.gov/service/medical-marijuana-and-integrative-therapy

Who “certifies” a patient? Who can “recommend” or “certify” a patient? Terminology – no prescription Maryland**: Physician Nurse Dentist Podiatrist **Must have Maryland controlled dangerous substance registration **Must be registered by the Maryland Medical Cannabis Commission (“MMCC”)

Who “certifies” a patient?, Cont’d Delaware Only “licensed physician” issues certification MD or OD D.C. Only the following licensed and in good standing to practice may “recommend”: Medicine Osteopathy advanced practice registered nursing Dentistry naturopathic medicine physician assistant

Must those who “certify” separately register with regulatory authority? Maryland Yes – must be registered with MMCC Delaware No; but Program may contact physician to verify Certification D.C. No

Conditions for which medical cannabis can be recommended - Maryland A chronic or debilitating disease or medical condition that results in a patient being admitted into hospice or receiving palliative care; or A chronic or debilitating disease or medical condition or the treatment of a chronic or debilitating disease or medical condition that produces: Cachexia, anorexia, or wasting syndrome; Severe or chronic pain; Severe nausea; Seizures; or Severe or persistent muscle spasms. Qualifying medical conditions listed on MMCC website include glaucoma and PTSD

Conditions for which medical cannabis can be recommended – Delaware Terminal illness, cancer, HIV, AIDS, decompensated cirrhosis, amyotrophic lateral sclerosis, agitation of Alzheimer's disease, post-traumatic stress disorder, intractable epilepsy, seizure disorder, or the treatment of these conditions. A chronic or debilitating disease or medical condition or its treatment that produces 1 or more of the following: cachexia or wasting syndrome; severe, debilitating pain that has not responded to previously prescribed medication or surgical measures for more than 3 months or for which other treatment options produced serious side effects; intractable nausea; seizures; severe and persistent muscle spasms, including those characteristic of multiple sclerosis.

Conditions for which medical cannabis can be recommended – D.C. HIV; AIDS; Glaucoma; Severe and persistent muscle spasm, such as multiple sclerosis; Cancer; or Other condition, that is chronic, debilitating for which the use of medical marijuana is beneficial Other condition for which treatment with medical marijuana would be beneficial, as determined by the patient's authorized practitioner [BROAD]

Maryland Requirements for Issuing Patient Certification Maryland Certifying provider must: (1) determine patient has registered with the Commission; (2) have a bona fide physician-patient relationship; (3) determine patient meets the certifying physician's inclusion criteria; (4) determine patient must not meet the certifying physician's exclusion criteria;

MD Requirements for Issuing Patient Certification, Cont’d Maryland Certifying provider must: (5) determine that the potential benefits of the medical use of cannabis likely outweigh the health risks for the patient. (6) Log onto the website of the Commission to transmit the written certification to the Commission; and (7) If requested, provide a copy of the written certification to the qualifying patient.

“Bona Fide Physician- Patient Relationship” - Maryland “Bona fide physician-patient relationship” means a treatment or counseling relationship between a physician and a patient in which the physician has: (a) Reviewed the patient's relevant medical records and completed an in person assessment of the patient's medical history and current medical condition; (b) Created and maintained records of the patient's condition in accord with medically accepted standards; and (c) A reasonable expectation that the physician will monitor the progress of the patient while using medical cannabis and take any medically indicated action: (i) To provide follow-up care to the patient; (ii) Regarding the efficacy of the use of medical cannabis as a treatment of the patient's severe or debilitating medical condition; and (iii) Regarding any adverse event associated with the use of medical cannabis. COMAR 10.62.01.01

“Bona Fide Physician- Patient Relationship” – Delaware & D.C. Requires “bona fide physician-patient relationship” bona fide physician-patient relationship may not be limited to authorization for the patient to use medical marijuana or consultation for that purpose D.C. Requires “bona fide relationship” Cannot be an owner, director, officer, member, incorporator, agent, or employee of a dispensary, cultivation center, or testing laboratory.

Reporting requirements of certifying providers Maryland Certifying provider must be registered with Commission Certifying provider must log onto the website of the Commission to transmit the written certification to the Commission Commission maintains and publishes a list of certifying providers Delaware Certifying providers do not generally centrally report certification, but provide a certification to patient The Program may contact the physician to verify the certification.

Reporting requirements of certifying providers, cont’d D.C. Providers do not generally centrally report recommendations, but sign patient applications and form is prescribed by Department for recommendations. Department maintains a confidential record, not subject to FOIA, of each recommending authorized practitioner for the purpose of monitoring compliance with the Act. Provider must notify the Department in writing within fourteen (14) calendar days after advising a qualifying patient that he or she no longer suffers from a qualifying medical or dental condition or treatment.

Protections to Providers who certify or recommend medical cannabis State law protections: Generally providers who certify/recommend in accordance with state law may not be subject to prosecution, civil penalty, or disciplinary action – state law only, not federal. Maryland: Md. Code, Health-Gen. § 13-3313(a)(3) Delaware: Del. Code tit. 16, § 4903A(g) D.C.: D.C. Code § 7-1671.04(c)

Protections to Providers who certify or recommend medical cannabis Federal Law Medical cannabis is illegal under federal law, thus there is no statutory or regulatory immunity to certifying providers from federal law. Conant v Walters (9th Cir. 2002) – Court recognizes federal government cannot punish or threaten to take away licensure solely because physician recommends medical cannabis to a patient – First Amendment concerns apply to relationship. Issue: is “certification” or “recommendation” as part of a state dispensing program protected? Rohrbacher limit on funding Bottom line: federal risk even if not significant

Maryland statistical snapshot Maryland statistics State population: 6.8 million Number of registered medical cannabis patients: 64,300 Approximately 24,300 licensed physicians in Maryland Number of registered providers: 1,075 Physicians: 684 Nursing: 320 Dental: 60 Podiatry: 11

QUESTIONS?